USPTO serial 79374677
XINSITOL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 26, 2024
- Examiner
- GULIANO, ROBERT N
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with XINSITOL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Zhuhai Trinomab Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
Zhuhai Trinomab Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
Zhuhai Trinomab Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scot A. Duvall
Scot A. Duvall STITES & HARBISON PLLC250 W. Main Street, Suite 2300Lexington, KY 40507United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of kidney disease; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of respiratory system disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; Biological preparations for medical purposes, namely, biological reagents for medical purposes; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; Biological preparations for medical purposes for the prevention and treatment of respiratory system disorders; Biological preparations for medical purposes for the prevention and treatment of immune system related diseases and disorders; Biological preparations for medical purposes for the prevention and treatment of infectious diseases, pain, cancer and tumors; Vaccines; Antiallergic medicines for human purposes; Medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer and antibiotics; Medicines for human purposes for the prevention and treatment of respiratory system disorders; Medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; Medicines for human purposes for the prevention and treatment of infectious diseases, pain, cancer and tumors; Diagnostic preparations for medical purposes; Dietetic foods and beverages adapted for medical use; Protein supplements for animals; Absorbent wadding for medical purposes | ACTIVE | — |
| 035 | Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; Marketing services; Commercial administration of the licensing of the goods and services of others; Presentation of goods on communication media, for retail purposes, namely, providing television home shopping services in the field of general consumer merchandise; Advertising services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Similar marks named XINSITOL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 24, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Dec 24, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 24, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 24, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 24, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 9, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 22, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 22, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 26, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 4, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 18, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 18, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 26, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 26, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 24, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 24, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 4, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 21, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 21, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 16, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 26, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 25, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 5, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 4, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 22, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 22, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 25, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 21, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 20, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |